Angiolipoma: Clinical Trials

1 trial for Angiolipoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Angiolipoma: new trials by email Literature Review of Angiolipoma trials Research Report on Angiolipoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
everolimus (RAD001) - Tuberous Sclerosis, Angiolipoma
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati202008-12-012013-09-18

Narrower conditions

Tuberous Sclerosis (1)

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hamartoma (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Malformations of Cortical Development (1)  ·  Malformations of Cortical Development, Group I (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Multiple Primary (1)  ·  Neoplastic Syndromes, Hereditary (1)  ·  Nervous System Diseases (1)  ·  Nervous System Malformations (1)

Interventions

Everolimus (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)

Countries

United States (1)

Top investigators

John Bissler, MD (1)